Cellular Connectivity Drives the Future of Telehealth

Remote patient monitoring has surged in recent years. With COVID‑19 lockdowns limiting in‑person visits, telehealth is set to become a mainstream care model, says Peter Fowler, SVP of Quectel.

The pandemic has pushed even patients who normally frequent hospitals to stay home. Telehealth lets them receive care without exposing themselves to the virus, and many are finding the model convenient, cost‑effective for insurers and providers, and rich in continuous data.

Telehealth’s benefits are especially pronounced in sparsely populated or hard‑to‑reach areas, where a clinician can only see a handful of patients per day.

According to research firm Berg Insight, roughly 18 million North Americans were already using connected‑health solutions at the end of 2018, with remote monitoring comprising the bulk. Pre‑COVID projections had that number climbing to 49.4 million by 2024; the pandemic is accelerating that trajectory.

Not all telehealth solutions are equal. Basic monitoring of chronic conditions—such as diabetes or sleep apnea—offers valuable snapshots but often lacks real‑time responsiveness. When devices are truly connected, clinicians can collect data at regular intervals, enabling seven‑day heart‑rate monitoring or detailed foot‑care analytics for diabetic patients.

Connecting Wearables

Integrating medical wearables can be tricky. Many patients, especially older adults, lack home Wi‑Fi or reliable, secure networks, raising safety concerns. Devices that are hard to set up, uncomfortable, or difficult to use are quickly abandoned.

Telehealth must rely on plug‑and‑play devices that simply power on and are ready for use. Anelto, a U.S. remote‑monitoring firm, is simplifying adoption by offering a two‑way communication system that tracks vital signs—heart rate, temperature, blood pressure, oxygen saturation, weight—and chronic‑condition indicators such as blood sugar.

Two‑Way Communications

Two‑way talk is a key driver of patient acceptance. Being able to speak with patients, guide them through device use, and capture their comments can improve diagnostic accuracy. In a landscape where U.S. physicians earn more for virtual visits and remote monitoring—a trend likely to continue post‑pandemic—enhancing patient engagement yields clear business benefits.

Enabling effortless setup is the bottleneck. Anelto leverages cellular connectivity to overcome the complexities of Wi‑Fi configuration. Cellular modules can be switched on and automatically connect, delivering secure, voice‑centric communications with high availability.

“Anelto is setting the standard for in‑home monitoring, which improves patient engagement, safety, and outcomes,” says Mark Denissen, CEO of Anelto. “Cellular capability ensures easy connection, reliable access, and secure data exchange. This reassures patients and encourages telehealth use. We’re thrilled with Quectel’s LTE modules and the support we receive.”

To power its devices, Anelto turned to Quectel for LTE modules that provide low‑latency, two‑way, voice‑centric, secure connectivity. Quectel was chosen for its reliability, extensive product portfolio, and value‑added services.

Telehealth is gaining traction. The travel restrictions and limited human contact that followed COVID‑19 lockdowns will push its adoption even further. Quectel is proud to make high‑performance LTE modules accessible to patients and providers, advancing the future of care.

The author is Peter Fowler, SVP of Quectel.

About the author

Peter Fowler launched Siemens Wireless Modules North America in 2002. Since then, the unit has changed hands, but the legacy remains. Today, Quectel claims to be the world’s largest module vendor. Fowler resides in Point Roberts, WA, and has three sons.